October 25, 2025 a 06:00 pm
CAH: Fundamental Ratio Analysis - Cardinal Health, Inc.
Cardinal Health, Inc. operates as a major player in the healthcare sector, providing integrated services and products worldwide. The stock presents a mixed investment opportunity with stable revenue streams but faces challenges within fiercely competitive markets.
Fundamental Rating
The fundamental assessment of Cardinal Health reveals a moderate rating with room for improvement in several financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Overall | 2 | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 1 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Comparing historical scores highlights consistent metrics, suggesting stability in operations.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-24 | 2 | 5 | 1 | 4 | 1 | 2 | 1 |
| N/A | 0 | 5 | 1 | 4 | 1 | 2 | 1 |
Analyst Price Targets
Analysts present a positive consensus on CAH, forecasting a potential upside in the stock price.
| High | Low | Median | Consensus |
|---|---|---|---|
| $189 | $150 | $181 | $177 |
Analyst Sentiment
Investor sentiment remains bullish, though a considerable portion maintains a hold stance.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 16 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Cardinal Health presents a solid investment opportunity in the healthcare distribution industry, bolstered by a robust product portfolio and global presence. However, potential investors should remain cautious about its moderate financial performance and stiff competition. The company's future success may largely depend on its strategic initiatives in the pharmaceutical and medical segments. Overall, the stock may appeal to those seeking value and stability with growth potential.